Chemosensitization
Author:
Lønning Per Eystein
Reference134 articles.
1. Abe, O., Abe, R., Enomoto, K., et al. (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352, 930–942. 2. Clarke, M., Collins, R., Davies, C., Godwin, J., Gray, R., and Peto, R. (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351, 1451–1467. 3. Taal, B. G., Van Tinteren, H., and Zoetmulder, F. (2001) Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br. J. Cancer 85, 1437–1443. 4. Henderson, I. C. and Patek, A. J. (1998) The relationship between prognostic and predictive factors in the management of breast cancer. Breast Cancer Res. Treat. 52, 261–288. 5. Ahr, A., Karn, T., Solbach, C., et al. (2002) Identification of high risk breast-cancer patients by gene expression profiling. Lancet 359, 131–132.
|
|